aTyr Pharma, Inc. (ATYR)
0.816
+0.01
(+0.95%)
USD |
NASDAQ |
Dec 10, 16:00
0.8159
0.00 (0.00%)
After-Hours: 06:08
aTyr Pharma Total Liabilities (Quarterly): 26.61M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Baxter International, Inc. | 13.85B |
| AVITA Medical, Inc. | 66.31M |
| AIM ImmunoTech, Inc. | 11.57M |
| Protalix Biotherapeutics, Inc. | 29.36M |
| Armata Pharmaceuticals, Inc. | 185.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 106.65M |
| Shareholders Equity (Quarterly) | 80.24M |
| Debt to Equity Ratio | 0.154 |
| Current Ratio | 5.933 |
| Net Debt Paydown Yield | 0.42% |